Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
FDA: Test Blood Donations for Zika Virus
As a further safety measure against the emerging Zika virus outbreak, today the U.
Ecological consequences of amphetamine pollution in urban streams
Millbrook, NY -- Public Release.
New method of cancer immunotherapy developed
SAN FRANCISCO, Aug.
Boosting brain protein alleviates Alzheimer's symptoms, study says
LA JOLLA, Calif.
FDA Accepts Clovis Oncology’s New Drug Application for Rucaparib for Priority Review for the Treatment of Advanced Mutant BRCA Ovarian Cancer
BOULDER, CO, USA -- August 23, 2016-- Clovis Oncology, Inc.
Amgen Provides Update On Status Of Parsabiv™ (Etelcalcetide) New Drug Application (NDA) Submitted To The U.S. Food And Drug Administration (FDA)
THOUSAND OAKS, CA, USA I August 24, 2016 I Amgen (Nasdaq.
Pharmaceutical company brings more investment to Greenville
A pharmaceutical development and manufacturing company announced Wednesday it is renovating an existing building to triple the capacity of its stability storage space.
Sleep hormone may suppress breast cancer growth
Suggesting a link between lack of sleep and increased risk of breast cancer, a new study has found that melatonin, a hormone produced in the human brain at night to regulate sleep cycles, appears to s...
Chinese scientists discover molecules to repair organs
XIAMEN, Aug.
U.K. finds big issues with Pfizer Hospira plant in India
Pfizer was well aware that a Hospira plant in India had a history of issues when it acquired the sterile injectable drug maker last year for $15 billion.
Pfizer to Buy Antibiotics From AstraZeneca for $725 Million
Pfizer Inc.
Major need for safer antiarrhythmic drugs will continue to plague atrial fibrillation market, says GlobalData
While the overall level of unmet need in the atrial fibrillation market is generally considered moderate, the need for safer antiarrhythmic drugs for the maintenance of sinus rhythm is still a major i...
596
597
598
599
600
601
602
603
604
